| Primary |
| Interstitial Lung Disease |
50.0% |
| Still's Disease Adult Onset |
50.0% |
|
| Anencephaly |
33.3% |
| Cytomegalovirus Infection |
33.3% |
| Subcutaneous Nodule |
33.3% |
|
| Secondary |
| Adult T-cell Lymphoma/leukaemia |
15.1% |
| Behcet's Syndrome |
13.1% |
| Prophylaxis Against Transplant Rejection |
12.8% |
| Hiv Infection |
10.2% |
| Rheumatoid Arthritis |
8.0% |
| Drug Therapy |
3.8% |
| Colitis Ulcerative |
3.5% |
| Juvenile Arthritis |
3.5% |
| Drug Use For Unknown Indication |
3.3% |
| Acute Lymphocytic Leukaemia |
2.9% |
| Psoriasis |
2.9% |
| Nutritional Support |
2.7% |
| Prophylaxis |
2.7% |
| Mycobacterium Avium Complex Infection |
2.6% |
| Pain |
2.4% |
| Gastritis |
2.2% |
| Gastroenteritis |
2.2% |
| Nephrotic Syndrome |
2.2% |
| Urinary Tract Infection |
2.2% |
| Coronary Artery Disease |
1.8% |
|
| Ileal Ulcer |
19.0% |
| Glucose Tolerance Impaired |
12.7% |
| Urosepsis |
9.5% |
| Urinary Tract Infection Enterococcal |
6.3% |
| Cryptococcosis |
4.8% |
| Infectious Peritonitis |
4.8% |
| Pneumocystis Jiroveci Pneumonia |
4.8% |
| Septic Shock |
4.8% |
| Encephalitis Viral |
3.2% |
| Gastric Ulcer |
3.2% |
| Intestinal Ulcer |
3.2% |
| Pseudomembranous Colitis |
3.2% |
| Small Intestinal Haemorrhage |
3.2% |
| Thermal Burn |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Vision Blurred |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Abscess Sterile |
1.6% |
| Acute Graft Versus Host Disease |
1.6% |
| Agranulocytosis |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.2% |
| Prophylaxis |
11.6% |
| Infection Prophylaxis |
9.3% |
| Prophylaxis Against Graft Versus Host Disease |
6.2% |
| Premedication |
4.5% |
| Rheumatoid Arthritis |
4.4% |
| Bone Marrow Conditioning Regimen |
4.0% |
| Colitis Ulcerative |
3.7% |
| Hiv Infection |
2.6% |
| Drug Use For Unknown Indication |
2.3% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Graft Versus Host Disease |
1.5% |
| Hypertension |
1.4% |
| Pneumonia |
1.2% |
| Vestibular Neuronitis |
1.1% |
| Constipation |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Primary Immunodeficiency Syndrome |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
0.9% |
| Diarrhoea |
0.8% |
|
| Uveitis |
10.1% |
| Diabetes Mellitus |
9.5% |
| Idiopathic Thrombocytopenic Purpura |
9.5% |
| Renal Disorder |
7.5% |
| Haemolytic Anaemia |
7.0% |
| Headache |
6.5% |
| Hodgkin's Disease |
6.0% |
| Cerebral Haemorrhage |
5.0% |
| Blood Lactate Dehydrogenase Increased |
4.0% |
| Vasculitis Necrotising |
4.0% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
3.5% |
| Vomiting |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Acute Graft Versus Host Disease In Skin |
3.0% |
| Graft Versus Host Disease In Skin |
3.0% |
| Oedema Peripheral |
3.0% |
| Pyrexia |
3.0% |
| Respiratory Failure |
3.0% |
| Cerebral Infarction |
2.5% |
| Dizziness |
2.5% |
|
